Position Overview

Bicara Therapeutics is seeking a strategic, innovative, and execution-focused Vice President, Market Access to build and lead the company’s global market access organization in preparation for the potential launch of Bicara’s lead oncology asset. Reporting to the Chief Commercial Officer, the VP, Market Access will be responsible for developing and executing comprehensive payer, pricing, reimbursement, trade, distribution, patient support, and access strategies that maximize patient access and optimize product value across key stakeholders.

This executive leader will serve as a critical member of the Commercial Leadership Team and work cross-functionally with Clinical Development, Medical Affairs, Regulatory, Finance, Legal, HEOR, Sales, Marketing, Commercial Operations, and Corporate Affairs to ensure launch readiness and long-term commercial success.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

Responsibilities

Market Access Strategy & Leadership

• Develop and execute the U.S. market access strategy for Bicara’s oncology lead asset and portfolio

• Establish a clear value and access vision that aligns clinical differentiation with payer, provider, and patient needs

• Lead market access planning from pre-launch through commercialization

• Build and lead a high-performing market access organization, including payer marketing, national accounts, trade and distribution, patient support, pricing, and access operations

Payer & Reimbursement

• Develop payer engagement strategies to secure optimal coverage, reimbursement, and formulary positioning

• Build and manage relationships with commercial payers, Medicare, Medicaid, integrated delivery networks, and specialty pharmacy stakeholders

• Lead account planning and contract strategy for national and regional payer organizations

• Anticipate and address reimbursement barriers impacting patient access

Pricing & Contracting

• Lead development of launch pricing strategy and gross-to-net planning

• Oversee contracting strategies across payers, specialty pharmacies, and distribution partners

• Partner closely with Finance to model access scenarios, rebate strategies, and forecast implications

• Ensure compliance with all pricing and government reporting requirements

Trade & Distribution

• Design and implement an optimal specialty distribution and channel strategy

• Lead selection and management of specialty pharmacies, specialty distributors, and third-party logistics partners

• Establish channel performance metrics and governance processes

• Ensure launch readiness across distribution, inventory management, and product access pathways

Patient Services & Access Programs

• Develop patient support and access programs that reduce barriers to therapy initiation and persistence

• Oversee hub services, benefits verification, copay assistance, patient assistance programs, and reimbursement support

• Ensure patient services are scalable, compliant, and aligned with customer needs

HEOR, Value & Evidence Generation

• Partner with Medical Affairs and HEOR to develop evidence generation plans that support payer value propositions

• Translate clinical and real-world evidence into compelling payer communications

• Ensure access strategies are informed by evolving evidence, treatment pathways, and stakeholder needs

Cross-Functional Leadership

• Serve as the commercial lead for market access within launch readiness team and across the organization

• Partner with Medical Affairs on payer engagement and evidence dissemination strategies

• Collaborate with Regulatory and Legal to ensure compliant stakeholder interactions

• Work closely with Commercial Operations to develop forecasting, targeting, contracting, and analytics capabilities

Team Building

• Recruit, develop, and retain top-tier market access talent

• Foster a culture of accountability, collaboration, innovation, and patient focus

• Establish organizational structure and capabilities appropriate for Bicara’s stage of growth

Basic Qualifications

• Bachelor’s degree required; advanced degree (MBA, PharmD, MPH, or related discipline) preferred

• 15+ years of biopharmaceutical industry experience with significant leadership responsibility in market access

• Demonstrated success leading market access strategy for oncology products

• Experience building market access capabilities in emerging biotechnology companies and/or leading launches in oncology

• Deep expertise across payer marketing, national accounts, pricing, contracting, reimbursement, trade, distribution, and patient services

• Proven ability to build and lead high-performing teams

Preferred Experience

• Experience launching specialty oncology products in the United States

• Experience with buy-and-bill reimbursement environments and complex oncology treatment pathways

• Familiarity with biomarker-driven oncology products and precision medicine

• Track record of successful cross-functional leadership in launch settings

Leadership Competencies

• Strategic thinker with strong execution capabilities

• Entrepreneurial mindset and comfort operating in a fast-paced biotech environment

• Strong executive presence and stakeholder influence skills

• Ability to navigate ambiguity and build infrastructure from the ground up

• Data-driven decision maker with strong financial acumen

• Passion for improving outcomes for people with cancer

Company Overview

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com.